ANURAS: first-half growth lifted margins, second-half revenue guidance set at INR 2,400–2,500 crore
ANURAS reported 21% income growth and 38% EBITDA growth for the first half of FY27 and set second-half consolidated revenue guidance.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
According to TradingView, ANURAS total income for the first half of fiscal 2027 (FY27) rose 21% year on year, while EBITDA climbed 38%. Margins improved over the period.
The company is widening its pharma platform through Bliss GVS. Consolidated revenue for the second half is guided at INR 2,400–2,500 crore.
why it matters
For investors, the combination of faster profit growth, better margins and a revenue outlook for the second half signals that the company's momentum is holding. This is an AI-generated summary, so key figures should be checked against the original source.
market impact
ANURAS shares: strong results and guidance support investor interest in the stock
- ANURAS shares pressure up — faster first-half growth and better margins support investor interest
tags
instruments
sources
- ANURAS: H1 growth strengthened margins as Bliss expanded the platform and H2 revenue guidance reached INR 2,400–2,500 crore — TradingView, 6 November 2026 at 13:22 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗